Travere Therapeutics Reports First Quarter 2024 Financial Results
Net product sales for the first quarter of 2024 were $40.0 million, compared to $24.2 million for the same period in 2023.
- Net product sales for the first quarter of 2024 were $40.0 million, compared to $24.2 million for the same period in 2023.
- Travere Therapeutics will host a conference call and webcast today, Monday, May 6, 2024, at 4:30 p.m.
- ET to discuss company updates as well as first quarter 2024 financial results.
- The Company believes that these non-GAAP financial measures are helpful in understanding its past financial performance and potential future results.